Caribou Biosciences, Inc.

Lead the design, execution, and interpretation of early-phase clinical trials for allogeneic CAR-T therapies in hematologic malignancies. Drive cross-functional collaboration and author key regulatory documents and study reports to advance innovative therapies.

Lead the strategic planning and operational execution of a high-priority hematology program, overseeing CROs and vendors to ensure timelines and budgets are met. Collaborate cross-functionally to drive integrated study execution and maintain high standards of data quality and inspection readiness.